Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy and safety of Pyrotinib Maleate Tablets in the treatment of advanced breast cancer patients with positive her-2.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Anhui Provincial Hospital
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT06708910 · HER2 Positive Breast Carcinoma
NCT06868758 · HER2 Positive Breast Carcinoma, Neoadjuvant Therapy
NCT03715959 · Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, and more
NCT02673398 · HER2 Positive Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions